論文專(zhuān)著：

出版著作或教材：

1.《中藥藥劑學(xué)》，中國(guó)中醫(yī)藥出版社， 編委， 2002.01，規(guī)劃教材。

2.《藥物制粒技術(shù)》， 化學(xué)工業(yè)出版社，主編， 2007.02，專(zhuān)著。

3.《藥劑學(xué)》，中國(guó)中醫(yī)藥出版社，主編，2011.02，規(guī)劃教材。

4.《中藥藥劑學(xué)》，人民衛(wèi)生出版社，主編， 2012.07，規(guī)劃教材。

5.《中藥藥劑學(xué)》，人民衛(wèi)生出版社，主編， 2016.04，規(guī)劃教材。

6.《實(shí)用制粒新技術(shù) 》，化學(xué)工業(yè)出版社，2005年12月，主編。

7.《中藥藥效研究思路與方法》，人民衛(wèi)生出版社，2004年12月，編委。

8.《中藥制藥工程學(xué) 》，人民衛(wèi)生出版社，2004年6月， 編委。

9.《中藥藥劑學(xué)  》，中國(guó)醫(yī)藥衛(wèi)生出版社，2001年8月，編委。 

發(fā)表英文部分論文： 

1. Mu CF, Shen J, Liang J, Zheng HS, Xiong Y, Wei YH, Li F. Targeted drug delivery for tumor therapy inside the bone marrow. Biomaterials. 2018,155:191-202. doi: 10.1016/j.biomaterials.2017.11.029.

2. Han S, Zheng H, Lu Y, Sun Y, Huang A, Fei W, Shi X, Xu X, Li J, Li F. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer. J Drug Target. 2018, 26(1):86-94. doi: 10.1080/1061186X.2017.1344849.

3. Chen, Cuiwei; Zheng, Hongyue; Xu, Junjun; Shi, Xiaowei; Li, Fanzhu*; Wang, Xuanshen*, Wang X. Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation. Daru. 2017, 4，25(1):20. doi: 10.1186/s40199-017-0186-9.

4. Yan, Binjun*; Bai, Xue; Sheng, Yunjie; Li, Fanzhu. Statistical Model Based HPLC Analytical Method Adjustment Strategy to Adapt to Different Sets of Analytes in Complicated Samples. Phytochem Anal. 2017, 28(5):424-432. doi: 10.1002/pca.2690.

5. Zhou, Jun; Ma, Xiaoqiong; Shi, Min; Chen, Cuiwei; Sun, Yue; Li, Jingjing; Xiong, Youxiang; Chen, Junjie; Li, Fanzhu*. Serum metabolomics analysis reveals that obvious cardioprotective effects of low dose Sini decoction against isoproterenol-induced myocardial injury in rats. Phytomedicine. 2017, 15，31:18-31. doi: 10.1016/j.phymed.2017.01.009.

6. Fei, Weidong; Zhang, Yan; Han, Shunping; Tao, Jiaoyang; Zheng, Hongyue; Wei, Yinghui; Zhu, Jiazhen; Li, Fanzhu*; Wang, Xuanshen*. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. Int J Pharm. 2017, 15，519(1-2):250-262. doi: 10.1016/j.ijpharm.2017.01.031.

7. Wei, Yinghui*; Luo, Xiaoting; Guan, Jiani; Ma, Jianping; Zhong, Yicong; Luo, Jingwen; Li, Fanzhu. Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics. Li FDrug Dev Ind Pharm. 2017, 43(11):1885-1891. doi: 10.1080/03639045.2017.1353519.

8.Zhang, Shi-rong; Xu, Ya-si; Jin, Er; Zhu, Lu-cheng; Xia, Bing; Chen, Xu-feng; Li, Fan-zhu*; Ma, Sheng-lin*.Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance. Acta Pharmacologica Sinica, 2017, 38(1): 100-109.

9.Wang, Juan; Wei, Yan; Fei, Ya-Rong; Fang, Li; Zheng, Hang-Sheng*; Mu, Chao-Feng; Li, Fan-Zhu; Zhang, Yong-Sheng.Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride. International Journal of Pharmaceutics, 2017, 533(1): 266-274.

10. Xu X, Li J, Han S, Tao C, Fang L, Sun Y, Zhu J, Liang Z, Li F. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Eur J Pharm Sci. 2016, 10，88:178-90. doi: 10.1016/j.ejps.2016.02.015.

11. Sun, Yue; Gu, Mancang*; Zhu, Lixin; Liu, Junying; Xiong, Yang; Wei, Yinghui; Li, Fanzhu. Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells. Anticancer Drugs. 2016, 27(3):183-191. doi: 10.1097/CAD.0000000000000315.

12.  Ning, Yuming; Rao, Yuefeng; Yu, Zhenwei; Liang, Wenquan; Li, Fanzhu*. Skin permeation profile and anti-inflammatory effect of anemonin extracted from weilingxian. Pharmazie. 2016, 71(3):134-138.

13.Chen, Cuiwei*; Hu, Yiqin; Shi, Xiaowei; Tao, Chenghao; Zheng, Hongyue; Fei, Weidong; Han, Shunping; Zhu, Jiazhen; Wei, Yinghui; Li, Fanzhu.A single-label fluorescent derivatization method for quantitative determination of neurotoxin in vivo by capillary electrophoresis coupled with laser-induced fluorescence detection. Analyst, 2016, 141(14): 4495-4501.

14.Xu, XiuLing; Li, JingJing; Han, ShunPing; Tao, ChengHao; Fang, Luo; Sun, Yue; Zhu, JiaZhen; Liang, ZeHua; Li, FanZhu* .A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. European Journal of Pharmaceutical Sciences, 2016, 88: 178-190.

15.Xiao, Xuecheng; Liu, Yangyang; Guo, Manman; Fei, Weidong; Zheng, Hongyue; Zhang, Rongrong; Zhang, Yan; Wei, Yinghui; Zheng, Guohua*; Li, Fanzhu. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo. Journal of Biomaterials Applications, 2016, 31(1): 23-35.

16.Xinjun Cai; Zeng Wang; Congyao Wang; Huijun Zhou; Jianjun Ni; Yingying Xu; Liyan Zhu; Tianhong Fu; Fanzhu Li; Sangsang Chen; Jianshe Zhou. In vitro and in vivo evaluation of cationic liposomes containing zoledronic acid as anticancer agent. Nanomedicine: Nanotechnology, Biology and Medicine , 2016, 12(2): 513-513.

17.EWei, Yinghui*; Guan, Jiani; Ma, Xiaoqiong; Zhong, Yicong; Ma, Jianping; Li, Fanzhu。ffect of glycyrrhizic acid on rhein renal penetration: a microdialysis study in rats. Xenobiotica, 2015, 45(12): 1116-1121.

18.Cai, Xinjun; Wang, Zeng; Wang, Congyao; Hj, Zhou; Ni, Jianjun; Xu, Yingying; Zhu, Liyan; Fu, Tianhong; Li, Fanzhu*; Chen, Sangsang; Zhou, Jianshe; Yang, Gaoyi. In Vitro and In Vivo Evaluation of Cationic Liposomes Containing Zoledronic Acid as Anticancer Agent.Latin American Journal of Pharmacy, 2015, 34(6): 1239-1245.

19.Wei, Yinghui; Guan, Jiani; Ma, Xiaoqiong; Zhong, Yicong; Ma, Jianping; Li, Fanzhu. Effect of glycyrrhizic acid on rhein renal penetration: a microdialysis study in rats. Xenobiotica, 2015, 45(12): 1116-1121.

20.Fang, Luo; Song, Yu; Weng, Xu; Li, Fanzhu; Xu, Yaping; Lin, Nengming*Highly sensitive HPLC-DAD method for the assay of gefitinib in patient plasma and cerebrospinal fluid: application to a blood-brain barrier penetration study.Biomedical Chromatography, 2015, 29(12): 1937-1940.

21.Fang, Luo; Sun, Xiaojiang; Song, Yu; Zhang, Yiwen; Li, Fanzhu; Xu, Yaping; Ma, Shenglin*; Lin, Nengming*.Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study. Cancer Chemother Pharmacol, 2015, 76(4): 873-877.

22.Sun, Yanwen; He, Yu*; Gu, Mancang; Chen, Jianzhen; Li, Fanzhu.Optimisation of the extraction conditions of natural colourant carthamin from safflower (Carthamus tinctorius L.) by response surface methodology.International Journal of Food Science and Technology, 2014, 49(4): 1168-1174.

23.Fang, Luo; Yang, Guonong; Song, Yu; Li, Fanzhu; Lin, Nengming. Application of isoabsorption plots generated by high-performance liquid chromatography with diode array detection to the development of multicomponent quantitative analysis of traditional herbal medicines. Journal of Separation Science, 2014, 37(22): 3245-3252.

24.Liu, Minchen; Ma, Xiaoqiong; Jin, Zhexiu; Li, Wuchao; Guo, Manman; Li, Fanzhu* .Determination and pharmacokinetic study of the diacid metabolite of norcantharidin in beagle plasma by use of liquid chromatography-tandem mass spectrometry.Analytical and Bioanalytical Chemistry, 2013, 405(28): 9273-9283.

25.Liu, Lin; Zhang, Xiangyi; Li, Wuchao; Sun, Haozhen; Lou, Yan; Zhang, Xingguo*; Li, Fanzhu. Transferrin receptor antibody-modified alpha-cobrotoxin-loaded nanoparticles enable drug delivery across the blood-brain barrier by intranasal administration. Journal of Nanoparticle Research, 2013, 15(11): UNSP 2059.

26.Zhang, Xingguo; Liu, Lin; Chai, Guobao; Zhang, Xiangyi; Li, Fanzhu*. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Drug Development and Industrial Pharmacy, 2013, 39(11): 1618-1624.

27.Lv, Qing; Li, Li-Min; Han, Min*; Tang, Xin-Jiang; Yao, Jin-Na; Ying, Xiao-Ying; Li, Fan-Zhu; Gao, Jian-Qing. Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome.International Journal of Pharmaceutics, 2013, 444(1-2): 1-9.

28.Gao, Jian-Qing; Lv, Qing; Li, Li-Ming; Tang, Xin-Jiang; Li, Fan-Zhu; Hu, Yu-Lan*; Han, Min. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.Biomaterials, 2013, 34(22): 5628-5639.

29.Zhang, Xingguo; Liu, Lin; Zhang, XiangYi; Ma, Kuifen; Rao, Yuefeng; Zhao, Qingwei; Li, Fanzhu*.Analytical methods for brain targeted delivery system in vivo: Perspectives on imaging modalities and microdialysis.Journal of Pharmaceutical and Biomedical Analysis, 2012, 59: 1-12.

30.Wei, Yinghui; Ye, Xiaoli; Shang, Xiaoguang; Peng, Xuan; Bao, Qiang; Liu, Minchen; Guo, Manman; Li, Fanzhu*.Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids and Surfaces A: Physicochemical and Engineering Aspects , 2012, 396: 22-28.

31.Cai, X.; Xu, Y.*; Li, F.; Wang, Z. .Application of nanotechnology in the control of lung tuberculosis.Drugs of the Future, 2012, 37(9): 659-661.

32.Han, Min; Lv, Qing; Tang, Xin-Jiang; Hu, Yu-Lan; Xu, Dong-Hang; Li, Fan-Zhu; Liang, Wen-Quan; Gao, Jian-Qing* .Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. Journal of Controlled Release, 2012, 163(2): 136-144.

33.Zhang Feng*; Ding Fei; Chu Xiao-Gang; Li Fan-Zhu; Yong Wei; Wang Xiu-Juan; Lue Quan-Fu; Xu Cheng-Bao.Simultaneous Determination of Three Barbitals in Feeds by Ultra-Performance Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry. Chinese Journal of Analytical Chemistry, 2011, 39(6): 788-792.

34.Xiao, Ren Zhong; Zeng, Zhao Wu*; Zhou, Guang Lin; Wang, Jun Jie; Li, Fan Zhu; Wang, An Ming .Recent advances in PEG-PLA block copolymer nanoparticles.International Journal of Nanomedicine, 2010, 5: 1057-1065.

35.Jin, Gui; Cheng, Qiaoyuan; Feng, Jian; Li, Fanzhu*.On-line microdialysis coupled to analytical systems. Journal of Chromatographic Science, 2008, 46(3): 276-287.

36.Wei, Y. H.; Xu, L. Z.; Liu, L.; Shen, Q.; Li, F. Z.*.Microdialysis: A Technique for Pharmacokinetic-Pharmacodynamic Studies of Oncological Drugs. Current Pharmaceutical Biotechnology, 2009, 10(6): 631-640.

37.Feng, Jian; Li, Fanzhu*; Zha, Yanmin; Feng, Yaorong; Abe, Youichi. Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats. International Journal of Pharmaceutics, 2009, 375(1-2): 55-60.

38.Cheng, Qiaoyuan; Feng, Jian; Chen, Jianming; Zhu, Xuan; Li, Fanzhu* .Brain Transport of Neurotoxin-I with PLA Nanoparticles through Intranasal Administration in Rats: A Microdialysis Study. Biopharmaceutics & Drug Disposition, 2008, 29(8): 431-439.

39.Yu W, Cheng Q, Feng J, Li F(通訊作者),Microdialysis for pharmacokinetic-pharmacodynamic studies.Pharmazie.2007 (Accepted) (SCI 收錄)

40.Gui Jin , Qiaoyuan Cheng, Jian Feng, Li, Fanzhu*(通訊作者),On-line microdialysis coupled to analytical system Journal of Chromatographic Science., 2008, 46(3): 276-287.(SCI 收錄)

41.Yue-fang Pan,Jian Feng,Qiao-yuan Cheng,Fan-zhu Li(通訊作者),Intracerebral Microdialysis Technique and its Application on Brain Pharmacokinetic-Pharmacodynamic Study. Arch Pharm Res Vol 30, 2007 (Accepted) (SCI 收錄)

42.Qiaoyuan Cheng, Jian Feng, Jianming Chen,Xuan Zhu and Fanzhu Li(通訊作者), Brain Transport of Neurotoxin-Ⅰ With PLA Nanoparticles Through Intranasal Administration in Rats: A Microdialysis Study. Biopharmaceutics and drug disposition. 2007 (Accepted) (SCI 收錄)

43. Fanzhu Li; Jian Feng; Qiaoyuan Cheng; Wenjing Zhu; Yuji Jin.Delivery of ¹²⁵I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely-moving rats. International Journal of Pharmaceutics, , 2007, 328(2): 161-167. (SCI 收錄)

44. Li FZ(通訊作者),shoji K,Nishiyama A,et al. Ischemic preconditioning protects post-ischemic renal function in anesthetized dogs: role of renal interstitial fluid adenosine and adenine nucleotides. Acta Pharmacology Sinica. 2005,6: 851-859 (SCI 收錄)  

45.QiaoyuanCHENG; WenjingZHU; JianFENG; JianmingCHEN; Fanzhu LI .Brain Transport of Neurotoxin-I With PLA Nanoparticles Through Intranasal Administration in Rats: A Microdialysis Study.China,Shanghai, 2007-01-01.

46. Akira NISHIYAMA,Yoshihide FUJISAWA,Toshiki FUKUI,Matlubur RAHMAN,Naoki,KONDO,Yoshihisa OGAWA,Li FANZHU ,et al. Role of Nitric Oxide in Regional Blood Flow in Angiotensin Ⅱ -Induced Hypertensive Rate. Hypertens Res.Vol.24,No.4(2001):421-427 (SCI 收錄) 

47. Yue W, Kimura S, Fujisawa Y, Tian R, Li F, Rahman M, Nishiyama A, Fukui T, Abe Y. Benidipine Dilates Both Pre-and Post-Glomerular Arteriole in the Canine Kidney. Hypertens Res.Vol.24,No.5(2001):429-436 (SCI 收錄) 

發(fā)表中文期刊論文：

[1]陳家琪,包丹丹,張悅,岳天祥,張鈳,李范珠,樸寄綱.附子-大黃藥對(duì)治療陽(yáng)虛類(lèi)疾病配伍機(jī)制研究進(jìn)展[J].中草藥,2022,53(11):3518-3530.

[2]單瑞平,鮑毅,尚海萍,沈珉霽,李范珠.他克莫司軟膏的制備及體外經(jīng)皮滲透評(píng)價(jià)[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2022,39(08):1082-1087.DOI:10.13748/j.cnki.issn1007-7693.2022.08.012.

[3]寧玉明,潘一帆,李范珠.丹參酮Ⅱ_A對(duì)阿霉素耐藥人乳腺癌細(xì)胞的多藥耐藥逆轉(zhuǎn)作用及機(jī)制研究[J].中草藥,2021,52(22):6890-6896.

[4]張鈳,岳天祥,程夢(mèng)瑩,梁曾穎,樸寄綱,鄭紅月,徐恒武,李范珠.線粒體靶向亞砷酸鈣/多柔比星脂質(zhì)納米粒的制備及其逆轉(zhuǎn)腫瘤耐藥性的體外研究[J].藥學(xué)學(xué)報(bào),2021,56(12):3243-3251.DOI:10.16438/j.0513-4870.2021-1169.

[5]張悅,劉愛(ài)迪,范旭東,岳天祥,樸寄綱,李范珠.中藥靶向遞送系統(tǒng)治療腦膠質(zhì)瘤研究進(jìn)展[J].中草藥,2021,52(17):5358-5368.

[6]楊建苗,王田田,韓旻,許東航,李范珠.線粒體靶向藥物聯(lián)合氯喹克服腫瘤多藥耐藥研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2021,38(15):1793-1797.DOI:10.13748/j.cnki.issn1007-7693.2021.15.001.

[7]包強(qiáng),閆志攀,肖正國(guó),喬莉,李喜香,劉效栓,李范珠.基于國(guó)家藥品標(biāo)準(zhǔn)的肺系病清熱類(lèi)中藥注射劑含量測(cè)定相關(guān)問(wèn)題概述[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2021,38(14):1665-1670.DOI:10.13748/j.cnki.issn1007-7693.2021.14.001.

[8]陳忠,阮葉萍,李范珠,黃真,朱喬青.基于“合和”思想的中藥學(xué)專(zhuān)業(yè)人才培養(yǎng)模式的構(gòu)建與實(shí)踐[J].中醫(yī)教育,2021,40(04):1-3+22.

[9]李武超,張平,王元,林茂銓,李范珠,朱志紅.D-甘露糖修飾黃芩苷陽(yáng)離子脂質(zhì)體的制備及其對(duì)肺癌A549細(xì)胞增殖的抑制作用[J].現(xiàn)代生物醫(yī)學(xué)進(jìn)展,2021,21(04):625-628+658.DOI:10.13241/j.cnki.pmb.2021.04.005.

[10]劉福和,倪文娟,俞松林,黃安皓,鄒佳峰,李范珠.羥基紅花黃色素A磷脂復(fù)合物自微乳給藥系統(tǒng)的制備及其在大鼠體內(nèi)的藥動(dòng)學(xué)研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2021,38(01):14-19.DOI:10.13748/j.cnki.issn1007-7693.2021.01.003.

[11]朱晶晶,陳曉劼,姚文棟,魏穎慧,鄭杭生,鄭紅月,朱志紅,王彬輝,李范珠.葉酸修飾的三氧化二砷前藥脂質(zhì)體的構(gòu)建及抗肝癌研究（英文）[J].Digital Chinese Medicine,2020,3(04):260-274.

[12]趙明星,姚文棟,李范珠,張?jiān)气P,張瑜,董顯文.超聲波光催化法制備亞微米銀膠體及其抑菌特性研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2020,37(15):1848-1855.DOI:10.13748/j.cnki.issn1007-7693.2020.15.009.

[13]李武超,郝武常,李范珠,林茂銓,王元.α-倒捻子素新型給藥系統(tǒng)研究進(jìn)展[J].中國(guó)藥業(yè),2020,29(13):1-5.

[14]楊建苗,許東航,李范珠.克服腫瘤多藥耐藥的藥物共遞送納米載體的設(shè)計(jì)及研究新方向[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2020,37(06):750-754.DOI:10.13748/j.cnki.issn1007-7693.2020.06.024.

[15]馬瑞,湯紅霞,陸燕平,陳曉劼,李范珠.氧化還原響應(yīng)性二氧化硅載三氧化二砷納米遞藥系統(tǒng)的制備及體外評(píng)價(jià)[J].中草藥,2020,51(06):1508-1516.

[16]王彬輝,章文紅,李范珠,葉曉莉,高曉宇,郭曼曼,戴東波.姜黃素聚乙二醇-聚己內(nèi)酯納米粒的藥動(dòng)學(xué)及其體外抗腫瘤作用[J].中國(guó)臨床藥學(xué)雜志,2020,29(01):1-6.DOI:10.19577/j.1007-4406.2020.01.001.

[17]夏愛(ài)曉,姚文棟,陳曉劼,蔣正立,李范珠.中華眼鏡蛇神經(jīng)毒素可溶性微針的制備及體外經(jīng)皮滲透性研究[J].中草藥,2020,51(03):625-630.

[18]鄭紅月,湯紅霞,王靜波,李超群,張琳,李范珠.基于中國(guó)知網(wǎng)+WIE模式剖析中醫(yī)藥院校期刊論文發(fā)表現(xiàn)狀[J].中醫(yī)藥管理雜志,2019,27(16):8-16.DOI:10.16690/j.cnki.1007-9203.2019.16.005.

[19]李武超,閆李麗,陳曉劼,李范珠,朱志紅.angiopep-2修飾的載FITC標(biāo)記的神經(jīng)毒素納米粒的制備及體外釋放研究[J].中國(guó)中藥雜志,2019,44(19):4171-4178.DOI:10.19540/j.cnki.cjcmm.20190630.301.

[20]鄒佳峰,朱志紅,李范珠,諸佳珍.Box-Behnken響應(yīng)面法優(yōu)化疏水改性普魯蘭納米粒的制備工藝[J].中國(guó)藥學(xué)雜志,2019,54(14):1154-1161.

[21]倪文娟,馬瑞,陸燕平,陳曉劼,程瀛,李范珠.載三氧化二砷腦膠質(zhì)瘤靶向納米遞藥系統(tǒng)i RGD/TGN-PEG-PAMAM/ATO的構(gòu)建及體外研究[J].中草藥,2019,50(09):2049-2056.

[22]王彬輝,鄒杰,章文紅,李范珠,高曉宇,陳玲,郭曼曼,葉曉莉.姜黃素聚乙二醇-聚己內(nèi)酯納米粒的制備及制劑學(xué)性質(zhì)分析[J].實(shí)用藥物與臨床,2019,22(03):307-311.DOI:10.14053/j.cnki.ppcr.201903021.

[23]熊友香,馬瑞,湯紅霞,李范珠.載去甲斑蝥素介孔二氧化硅納米粒的制備及體外釋藥研究[J].江西中醫(yī)藥大學(xué)學(xué)報(bào),2018,30(04):76-78.

[24]李囡囡,費(fèi)偉東,張燕,夏成凱,李范珠.mPEG修飾的新藤黃酸介孔硅納米粒的制備及體外評(píng)價(jià)[J].中國(guó)醫(yī)院藥學(xué)雜志,2018,38(14):1451-1457.DOI:10.13286/j.cnki.chinhosppharmacyj.2018.14.02.

[25]熊友香,湯紅霞,馬瑞,李范珠.去甲斑蝥素/粉防己堿雙載藥脂質(zhì)體的制備工藝及體外釋放性質(zhì)考察[J].中國(guó)中藥雜志,2018,43(12):2531-2536.DOI:10.19540/j.cnki.cjcmm.20180514.007.

[26]陶成浩,鄭紅月,姚文棟,湯紅霞,馬瑞,諸佳珍,李范珠.Angiopep-2修飾載神經(jīng)毒素介孔二氧化硅脂質(zhì)囊納米粒的制備及其體內(nèi)外評(píng)價(jià)[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2018,35(04):467-471.DOI:10.13748/j.cnki.issn1007-7693.2018.04.002.

[27]張燕,費(fèi)偉東,陶姣陽(yáng),鄒佳峰,陸燕平,李范珠.Angiopep-2修飾的載三氧化二砷介孔二氧化硅脂質(zhì)囊納米遞藥系統(tǒng)的構(gòu)建及體外評(píng)價(jià)[J].中草藥,2018,49(06):1289-1297.

[28]費(fèi)偉東,陶姣陽(yáng),宋倩倩,趙云春,楊昊堃,諸佳珍,李范珠.生物可降解介孔硅納米粒的研究進(jìn)展[J].藥學(xué)學(xué)報(bào),2018,53(05):716-726.DOI:10.16438/j.0513-4870.2017-1181.

[29]黃安皓,韓順平,陸燕平,馬瑞,鄭杭生,李范珠.RGDyC與PEG共修飾的PAMAM樹(shù)狀大分子載三氧化二砷腦膠質(zhì)瘤靶向遞藥系統(tǒng)的制備及體外評(píng)價(jià)[J].中國(guó)中藥雜志,2018,43(08):1618-1625.DOI:10.19540/j.cnki.cjcmm.20180117.010.

[30]陳建真,何昱,黃真,程汝濱,李范珠.基于建構(gòu)主義理論的中藥化學(xué)和天然藥物化學(xué)開(kāi)放互動(dòng)教學(xué)模式的實(shí)踐[J].中醫(yī)教育,2017,36(05):36-38.

[31]張巍,蔡犇,李范珠.頂空氣相色譜法測(cè)定依帕司他有機(jī)溶劑殘留量[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2017,34(09):1286-1288.DOI:10.13748/j.cnki.issn1007-7693.2017.09.015.

[32]韓順平,李晶晶,黃安皓,孫悅,施曉偉,徐秀玲,李范珠.聚乙二醇接枝率對(duì)第五代聚酰胺-胺樹(shù)狀大分子體外毒性與細(xì)胞攝取的影響[J].中國(guó)藥學(xué)雜志,2017,52(01):41-46.

[33]陳建真,李范珠,黃真,何昱,梁澤華.基于行業(yè)-專(zhuān)業(yè)-學(xué)科三位一體的特色專(zhuān)業(yè)建設(shè)模式[J].藥學(xué)教育,2016,32(06):20-23.DOI:10.16243/j.cnki.32-1352/g4.2016.06.005.

[34]何昱,李范珠,陳建真,鄭艷秋,張冰冰.混合式學(xué)習(xí)理念在中藥學(xué)專(zhuān)業(yè)建設(shè)中的構(gòu)建[J].藥學(xué)教育,2016,32(05):23-26.DOI:10.16243/j.cnki.32-1352/g4.2016.05.006.

[35]鄭杭生,王娟,李范珠,陳思思,黃繩武.基于現(xiàn)代信息技術(shù)改革藥劑學(xué)傳統(tǒng)教學(xué)模式的思考[J].藥學(xué)教育,2016,32(02):51-53.DOI:10.16243/j.cnki.32-1352/g4.2016.02.016.

[36]陳建真,何昱,李范珠.基于自主學(xué)習(xí)能力的中藥化學(xué)微課教學(xué)研究[J].中國(guó)醫(yī)學(xué)教育技術(shù),2016,30(02):174-177.DOI:10.13566/j.cnki.cmet.cn61-1317/g4.201602017.

[37]寧玉明,祝曉紅,李范珠.輪值夜班對(duì)浙江省富陽(yáng)市基層醫(yī)院藥師職業(yè)倦怠的影響[J].環(huán)境與職業(yè)醫(yī)學(xué),2015,32(11):1029-1032.DOI:10.13213/j.cnki.jeom.2015.14728.

[38]鄭杭生,陳思思,王娟,李范珠.《藥劑學(xué)》PBL教學(xué)的問(wèn)題設(shè)計(jì)與實(shí)踐[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2015,39(11):836-840.DOI:10.16466/j.issn1005-5509.2015.11.019.

[39]李晶晶,郭曼曼,韓順平,孫悅,費(fèi)偉東,徐秀玲,李范珠.共修飾冰片和葉酸的阿霉素聚酰胺-胺納米給藥系統(tǒng)的制備及體外評(píng)價(jià)[J].藥學(xué)學(xué)報(bào),2015,50(07):899-905.DOI:10.16438/j.0513-4870.2015.07.005.

[40]梁澤華,李范珠,楊元宵,翁錦妮,許夢(mèng)捷,徐姍姍.附子細(xì)辛、芍藥甘草配伍前后對(duì)小鼠鎮(zhèn)痛作用研究[J].亞太傳統(tǒng)醫(yī)藥,2015,11(10):13-15.

[41]胡亦沁,李元圓,徐駿軍,李范珠.HPCE與HPLC測(cè)定科博肽注射液含量的方法比較[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2015,32(05):564-567.DOI:10.13748/j.cnki.issn1007-7693.2015.05.011.

[42]王國(guó)偉,費(fèi)偉東,張蓉蓉,郭曼曼,徐駿軍,李范珠.Angiopep-2修飾核-殼介孔二氧化硅脂質(zhì)囊納米粒的制備及體外評(píng)價(jià)[J].中國(guó)藥學(xué)雜志,2015,50(09):775-783.

[43]郭曼曼,王國(guó)偉,徐駿軍,李晶晶,管佳妮,費(fèi)偉東,李范珠.載三氧化二砷pH值響應(yīng)介孔二氧化硅納米粒的制備及體內(nèi)外評(píng)價(jià)[J].中草藥,2015,46(07):982-989.

[44]徐駿軍,王國(guó)偉,郭曼曼,費(fèi)偉東,李范珠.載艾塞那肽介孔二氧化硅納米粒的研制及其藥動(dòng)學(xué)[J].中國(guó)醫(yī)藥工業(yè)雜志,2015,46(04):364-369.DOI:10.16522/j.cnki.cjph.2015.04.014.

[45]張蓉蓉,王國(guó)偉,徐駿軍,屠鈺,楊亞冬,李范珠.載白藜蘆醇的氨基修飾介孔二氧化硅納米粒的制備及體內(nèi)體外評(píng)價(jià)[J].中國(guó)藥學(xué)雜志,2015,50(05):413-419.

[46]蔡鑫君,王增,倪堅(jiān)軍,曹佳薇,姚君,徐穎穎,李范珠.唑來(lái)膦酸脂質(zhì)體的制備及對(duì)腫瘤細(xì)胞的抑制作用[J].中國(guó)臨床藥學(xué)雜志,2015,24(01):1-4.DOI:10.19577/j.cnki.issn10074406.2015.01.001.

[47]倪珊珊,廖廣輝,張廣順,申力,錢(qián)旭武,李范珠,張光霽.三氧化二砷與隱丹參酮不同配比對(duì)人肝癌HepG2裸鼠移植瘤的抑制作用[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2015,39(01):62-66.DOI:10.16466/j.issn1005-5509.2015.01.018.

[48]呂長(zhǎng)江,張蓉蓉,周軍,李穎芳,王國(guó)偉,李范珠.冰片鴉膽子油納米乳的制備及對(duì)大鼠腦膠質(zhì)瘤的抑瘤作用研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2014,31(07):780-786.DOI:10.13748/j.cnki.issn1007-7693.2014.07.002.

[49]呂長(zhǎng)江,劉福和,王國(guó)偉,郭曼曼,戴東波,魏穎慧,李范珠.當(dāng)歸補(bǔ)血顆粒對(duì)大鼠腎缺血再灌注損傷的保護(hù)機(jī)制研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2014,31(06):666-671.DOI:10.13748/j.cnki.issn1007-7693.2014.06.006.

[50]鄭杭生,李范珠,張彤.關(guān)于在藥學(xué)英語(yǔ)教學(xué)中增加小型專(zhuān)題講座的思考[J].安徽醫(yī)藥,2014,18(06):1196-1198.

[51]魏穎慧,吳素香,李范珠.多元互動(dòng)教學(xué)模式在《新產(chǎn)品開(kāi)發(fā)概論》課程中的應(yīng)用[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2014,38(05):641-643+647.DOI:10.16466/j.issn1005-5509.2014.05.002.

[52]李武超,劉敏臣,馬小瓊,魏穎慧,張蓉蓉,孫悅,李范珠.LC-MS/MS法測(cè)定去甲斑蝥素在大鼠體內(nèi)的組織分布[J].北京中醫(yī)藥大學(xué)學(xué)報(bào),2014,37(04):263-268.

[53]劉福和,葉曉莉,宋倩倩,魏穎慧,李范珠.雷公藤內(nèi)酯醇抗腫瘤信號(hào)轉(zhuǎn)導(dǎo)機(jī)制研究進(jìn)展[J].中華中醫(yī)藥學(xué)刊,2014,32(04):727-730.DOI:10.13193/j.issn.1673-7717.2014.04.007.

[54]尤佳,戴東波,何雯潔,李剛,宋述程,魏穎慧,李范珠,徐秀玲.姜黃素長(zhǎng)循環(huán)脂質(zhì)體的制備及藥動(dòng)學(xué)研究[J].中國(guó)中藥雜志,2014,39(07):1238-1242.

[55]何雯潔,何曉瑋,戴東波,尤佳,魏穎慧,李范珠.尼莫地平/川芎嗪雙載藥納米粒的制備及腦內(nèi)分布研究[J].中國(guó)藥學(xué)雜志,2014,49(06):479-484.

[56]方蓉,鄭杭生,李范珠,黃繩武.HPLC法測(cè)定三七總皂苷傳遞體中2個(gè)成分的含量和包封率[J].藥物分析雜志,2014,34(02):264-268.DOI:10.16155/j.0254-1793.2014.02.007.

[57]戴東波,尤佳,何雯潔,王彬輝,李范珠,徐秀玲.姜黃素聚乙二醇-聚乳酸嵌段共聚物納米粒的制備及其質(zhì)量評(píng)價(jià)[J].中草藥,2014,45(02):194-199.

[58]葉姣云,李范珠,葛松松.高等醫(yī)學(xué)院校開(kāi)展藥學(xué)職業(yè)道德教育新探[J].藥學(xué)教育,2013,29(06):13-15.DOI:10.16243/j.cnki.32-1352/g4.2013.06.005.

[59]孫淵,宋倩倩,李范珠,夏愛(ài)曉.長(zhǎng)春新堿固體脂質(zhì)納米粒藥動(dòng)學(xué)和體外抗腫瘤研究[J].中國(guó)新藥與臨床雜志,2013,32(12):965-969.

[60]董玲,彭代銀,喬延江,陶建生,田景振,張艷軍,李范珠.國(guó)外高校教師發(fā)展現(xiàn)狀研究及其啟示[J].中醫(yī)教育,2013,32(06):12-15.

[61]諸佳珍,李范珠.阿霉素自組裝納米粒的制備及其抗腫瘤活性的研究[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2013,37(08):951-955.DOI:10.16466/j.issn1005-5509.2013.08.001.

[62]徐穎穎,蔡鑫君,葉曉莉,李穎芳,王叢瑤,李范珠.利福平聚乳酸-羥基乙酸共聚物納米粒霧化吸入給藥肺靶向性研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2013,30(07):755-758.DOI:10.13748/j.cnki.issn1007-7693.2013.07.022.

[63]呂長(zhǎng)江,王國(guó)偉,戴東波,李范珠,陳靜,魏穎慧.四逆湯噴干粉中烏頭生物堿大鼠體內(nèi)吸收動(dòng)力學(xué)研究[J].中國(guó)中藥雜志,2013,38(14):2384-2388.

[64]李穎芳,蔡鑫君,戴東波,徐穎穎,李范珠.利福平PLGA納米粒的制備及霧化吸入給藥后在大鼠體內(nèi)的藥動(dòng)學(xué)[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2013,37(05):502-505.DOI:10.16466/j.issn1005-5509.2013.05.059.

[65]李靜,周英,徐秀玲,王海南,魏穎慧,郭曼曼,李范珠.殼聚糖修飾的雷公藤甲素聚乙二醇-聚乳酸納米粒的制備及質(zhì)量評(píng)價(jià)[J].中國(guó)藥學(xué)雜志,2013,48(09):700-704.

[66]夏愛(ài)曉,宋倩倩,孫淵,周鵬,杜有功,李范珠.硫酸長(zhǎng)春新堿固體脂質(zhì)納米粒的制備及其性質(zhì)考察[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2013,30(02):163-169.DOI:10.13748/j.cnki.issn1007-7693.2013.02.006.

[67]陳修克,魏穎慧,姚金娜,趙燕敏,尚小廣,李范珠.殼聚糖修飾的雷公藤多苷納米粒的制備及其腎靶向性研究[J].中國(guó)中藥雜志,2013,38(04):548-552.

[68]金滔,彭花楠,姚金娜,戴東波,李范珠.替莫唑胺白蛋白納米粒的制備及其腦內(nèi)遞藥特性研究[J].中國(guó)醫(yī)藥工業(yè)雜志,2013,44(01):41-45.DOI:10.16522/j.cnki.cjph.2013.01.013.

[69]魏穎慧,趙燕敏,李靜,徐小玉,郭曼曼,李范珠.殼聚糖修飾雷公藤多苷納米粒的制備及其體外釋藥研究[J].中草藥,2013,44(05):541-546.

[70]高曉宇,王叢瑤,魏穎慧,徐秀玲,鄭杭生,葉姣云,李范珠.氨茶堿貼片的制備及家兔臍部給藥的藥動(dòng)學(xué)研究[J].中國(guó)藥學(xué)雜志,2012,47(23):1925-1930.

[71]鄭杭生,黃繩武,李范珠,徐蓮英.鹽酸青藤堿脂質(zhì)體的制備工藝研究[J].中草藥,2013,44(04):408-413.

[72]呂清,韓旻,李黎明,鄭艷榕,李范珠,高建青.雙配體修飾的阿霉素脂質(zhì)體靶向于腦膠質(zhì)瘤的體外研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2012,29(11):963-970.DOI:10.13748/j.cnki.issn1007-7693.2012.11.017.

[73]蔡鑫君,徐穎穎,李范珠,葉曉莉.利福平聚乳酸-羥基乙酸共聚物納米粒的成型工藝及制劑學(xué)性質(zhì)分析[J].中國(guó)臨床藥學(xué)雜志,2012,21(04):210-213.DOI:10.19577/j.cnki.issn10074406.2012.04.003.

[74]王叢瑤,鄭杭生,谷滿倉(cāng),陳蘋(píng)蘋(píng),金滔,李范珠.鹽酸阿霉素殼聚糖納米粒大鼠鼻腔給藥的腦內(nèi)藥動(dòng)學(xué)研究[J].中國(guó)藥理學(xué)通報(bào),2012,28(07):994-999.

[75]吳素香,李范珠.藥物制劑設(shè)備與車(chē)間工藝設(shè)計(jì)實(shí)踐性教學(xué)建設(shè)的探索[J].中國(guó)高等醫(yī)學(xué)教育,2012(06):70-71.

[76]尚小廣,李穎,徐陸忠,魏穎慧,包強(qiáng),李范珠.大黃酸聚乳酸納米粒的制備及大鼠體內(nèi)藥動(dòng)學(xué)研究[J].中國(guó)藥學(xué)雜志,2012,47(07):524-528.

[77]宋倩倩,王選深,倪玲,包強(qiáng),李范珠.胸腺?lài)姸◆燃谆鶜ぞ厶潜丘つそo藥微球的制備及對(duì)大鼠CD4~+/CD8~+值的影響[J].中國(guó)醫(yī)藥工業(yè)雜志,2012,43(01):35-39.

[78]毛澤玲,馮健,李范珠.膽微透析技術(shù)及其在藥學(xué)研究中的應(yīng)用[J].中華中醫(yī)藥學(xué)刊,2012,30(01):35-38.DOI:10.13193/j.archtcm.2012.01.37.maozl.077.

[79]姚金娜,陳蘋(píng)蘋(píng),尚小廣,李范珠.水飛薊賓過(guò)飽和自微乳給藥系統(tǒng)在大鼠體內(nèi)的藥動(dòng)學(xué)研究[J].中草藥,2011,42(11):2261-2264.

[80]葉曉莉,王選深,王彬輝,魏穎慧,馮健,包強(qiáng),李范珠.pH依賴(lài)-時(shí)滯型大黃素結(jié)腸定位微丸的制備及體外釋藥研究[J].中草藥,2011,42(10):1956-1962.

[81]柳琳,張幸國(guó),李范珠.微透析與分析系統(tǒng)聯(lián)用的研究進(jìn)展[J].中國(guó)藥學(xué)雜志,2011,46(19):1457-1460.

[82]諸佳珍,王斌艷,陳蘋(píng)蘋(píng),馮健,魏穎慧,李范珠.萬(wàn)通炎康分散片的研制[J].中成藥,2011,33(08):1439-1442.

[83]金倩倩,陳修克,金滔,諸佳珍,尚小廣,劉敏臣,李范珠.大豆異黃酮對(duì)鹽酸雷洛昔芬在大鼠體內(nèi)的藥動(dòng)學(xué)研究[J].中藥藥理與臨床,2011,27(04):40-43.DOI:10.13412/j.cnki.zyyl.2011.04.025.

[84]華圓,馮健,李范珠.茵陳蒿湯利膽退黃物質(zhì)基礎(chǔ)的研究進(jìn)展[J].中華中醫(yī)藥學(xué)刊,2011,29(07):1520-1521.DOI:10.13193/j.archtcm.2011.07.74.huay.073.

[85]何曉瑋,趙燕敏,包強(qiáng),葉曉莉,李范珠.納米載體提高難溶性藥物口服生物利用度的研究進(jìn)展[J].國(guó)際藥學(xué)研究雜志,2011,38(03):212-215.DOI:10.13220/j.cnki.jipr.2011.03.012.

[86]張峰,丁菲,儲(chǔ)曉剛,李范珠,雍煒,王秀娟,呂泉福,許成保.超高效液相色譜-四極桿飛行時(shí)間質(zhì)譜測(cè)定動(dòng)物飼料中3種巴比妥類(lèi)違禁藥物[J].分析化學(xué),2011,39(06):788-792.

[87]丁菲,李范珠,儲(chǔ)曉剛,張峰.近年來(lái)全球防治心臟病保健植物藥研究進(jìn)展[J].安徽醫(yī)藥,2011,15(03):272-274.

[88]葉姣云,趙寧,陳蘋(píng)蘋(píng),李范珠.RP-HPLC梯度洗脫法測(cè)定四逆湯中烏頭類(lèi)生物堿的含量[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2011,35(02):289-291.DOI:10.16466/j.issn1005-5509.2011.02.043.

[89]柳琳,趙燕敏,李范珠.神經(jīng)毒素自組裝核殼型納米粒大鼠鼻黏膜給藥腦內(nèi)藥動(dòng)學(xué)研究[J].中國(guó)藥學(xué)雜志,2011,46(03):203-207.

[90]丁菲,李范珠,儲(chǔ)曉剛,張峰,凌云,孫利,楊敏莉,呂泉福,許成保.玉米中9種磺酰脲類(lèi)除草劑的超高效液相色譜-串聯(lián)質(zhì)譜法同時(shí)測(cè)定[J].分析測(cè)試學(xué)報(bào),2011,30(01):53-57.

[91]趙燕敏,夏愛(ài)曉,魏穎慧,阮葉萍,李范珠.聚山梨酯80修飾的神經(jīng)毒素納米�？缪�腦屏障轉(zhuǎn)運(yùn)及細(xì)胞毒性[J].藥學(xué)學(xué)報(bào),2010,45(10):1312-1316.DOI:10.16438/j.0513-4870.2010.10.020.

[92]李范珠,包強(qiáng),趙燕敏,陳蘋(píng)蘋(píng),阮葉萍,楊元宵.發(fā)揮高校科研實(shí)驗(yàn)室作用,加強(qiáng)大學(xué)生創(chuàng)新能力培養(yǎng)[J].實(shí)驗(yàn)技術(shù)與管理,2010,27(09):21-23.DOI:10.16791/j.cnki.sjg.2010.09.007.

[93]徐陸忠,趙燕敏,潘越芳,魏穎慧,李范珠.神經(jīng)毒素納米粒的制備及在大鼠體內(nèi)的組織分布[J].中國(guó)醫(yī)院藥學(xué)雜志,2010,30(17):1425-1428.

[94]陳蘋(píng)蘋(píng),趙寧,徐秀玲,阮葉萍,魏穎慧,李范珠.液相色譜-電噴霧串聯(lián)質(zhì)譜法分析新烏頭堿在大鼠尿液中的代謝產(chǎn)物[J].藥學(xué)學(xué)報(bào),2010,45(08):1043-1047.DOI:10.16438/j.0513-4870.2010.08.001.

[95]馮健,趙燕敏,李范珠.低共熔吸收促進(jìn)劑對(duì)神經(jīng)毒素鼻腔給藥腦內(nèi)遞藥的影響[J].中國(guó)藥學(xué)雜志,2010,45(13):1011-1015.

[96]包強(qiáng),蔡鑫君,李范珠.不同粒徑神經(jīng)毒素-Ⅰ納米粒大鼠鼻腔給藥腦藥動(dòng)學(xué)研究[J].中國(guó)藥理學(xué)通報(bào),2010,26(06):731-735.

[97]馮健,李范珠.中醫(yī)院校藥學(xué)類(lèi)教育考試模式改革之探討[J].中國(guó)高等醫(yī)學(xué)教育,2010(06):18-19.

[98]魏穎慧,陳蘋(píng)蘋(píng),李范珠.囊泡及微粒經(jīng)皮給藥系統(tǒng)的研究進(jìn)展[J].中國(guó)醫(yī)藥工業(yè)雜志,2010,41(03):224-229.

[99]王斌艷,夏愛(ài)曉,陳蘋(píng)蘋(píng),倪玲,劉福和,李范珠.載藥納米粒透過(guò)血腦屏障機(jī)制的研究進(jìn)展[J].國(guó)際藥學(xué)研究雜志,2010,37(01):40-42.DOI:10.13220/j.cnki.jipr.2010.01.010.

[100]彭璇,陳蘋(píng)蘋(píng),包強(qiáng),魏穎慧,李范珠.水飛薊賓過(guò)飽和自乳化給藥系統(tǒng)的制備及性質(zhì)研究[J].中草藥,2010,41(01):40-44.

[101]劉福和,趙燕敏,馮健,魏穎慧,李范珠.聚山梨酯-80包裹神經(jīng)毒素-Ⅰ聚氰基丙烯酸正丁酯納米粒腦內(nèi)藥動(dòng)學(xué)研究[J].中草藥,2009,40(11):1760-1763.

[102]倪玲,關(guān)巍岱,俞文英,魏穎慧,李范珠.生血微丸膠囊質(zhì)量標(biāo)準(zhǔn)的研究[J].中成藥,2009,31(10):1535-1539.

[103]王彬輝,馮健,趙燕敏,魏穎慧,徐銘,李范珠.附子中烏頭類(lèi)生物堿在大鼠體內(nèi)的藥動(dòng)學(xué)研究[J].中國(guó)藥學(xué)雜志,2009,44(18):1412-1415.

[104]徐珊,阮葉萍,徐燕立,任蕾萍,李范珠.健力方顆粒抗疲勞的實(shí)驗(yàn)研究[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2009,33(05):659-661.DOI:10.16466/j.issn1005-5509.2009.05.029.

[105]柳琳,徐陸忠,何曉瑋,趙燕敏,馮健,李范珠.神經(jīng)毒素自組裝核殼型納米粒的制備及其體外釋藥研究[J].中國(guó)藥學(xué)雜志,2009,44(14):1084-1088.

[106]徐陸忠,柳琳,魏穎慧,李范珠.微透析技術(shù)在藥物-蛋白結(jié)合研究中的應(yīng)用[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2009,26(05):364-368.

[107]柴國(guó)寶,魏穎慧,馮健,程巧鴛,李范珠.殼聚糖修飾的神經(jīng)毒素納米粒的制備及體外釋放研究[J].中國(guó)藥科大學(xué)學(xué)報(bào),2009,40(02):116-119.

[108]柴國(guó)寶,馮健,李范珠.載脂蛋白修飾聚氰基丙烯酸丁酯納米粒介導(dǎo)藥物跨血腦屏障的研究進(jìn)展[J].中國(guó)藥學(xué)雜志,2009,44(08):561-563.

[109]柴國(guó)寶,潘越芳,李范珠.冰片-薄荷腦低共熔物對(duì)神經(jīng)毒素納米粒鼻腔給藥載藥入腦的影響[J].中國(guó)中藥雜志,2009,34(06):698-701.

[110]柳琳,蔡鑫君,柴國(guó)寶,夏愛(ài)曉,趙寧,李范珠.自組裝納米粒及其作為藥物載體的研究進(jìn)展[J].中草藥,2009,40(03):479-483.

[111]阮葉萍,胡秀敏,劉云霞,李范珠.益氣補(bǔ)腎口服液對(duì)體外腫瘤浸潤(rùn)淋巴細(xì)胞的作用研究[J].當(dāng)代醫(yī)學(xué),2009,15(04):136-138.

[112]胡一平,張如松,成信法,李范珠,朱喬青.深化高校校院二級(jí)教學(xué)管理體制改革的探討[J].中國(guó)高等醫(yī)學(xué)教育,2009(01):9-10+13.

[113]夏道宗,王慧銘,李范珠,蔣立勤,夏明.現(xiàn)代科技革命對(duì)食品安全的影響及其倫理學(xué)思考[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2008(06):710-711.DOI:10.16466/j.issn1005-5509.2008.06.081.

[114]蔡鑫君,柳琳,程巧鴛,李范珠.噴霧干燥法制備神經(jīng)毒素-Ⅰ殼聚糖鼻腔給藥微球[J].中國(guó)醫(yī)藥工業(yè)雜志,2008(11):830-833.

[115]喬梁,魏穎慧,李范珠.過(guò)飽和自微乳釋藥系統(tǒng)的研究進(jìn)展[J].國(guó)際藥學(xué)研究雜志,2008(04):279-283.DOI:10.13220/j.cnki.jipr.2008.04.025.

[116]李范珠,徐陸忠,魏穎慧.大學(xué)生創(chuàng)新人才實(shí)驗(yàn)基地的構(gòu)建與實(shí)踐[J].中國(guó)高等醫(yī)學(xué)教育,2008(08):11-12.

[117]蔡鑫君,程巧鴛,趙寧,李范珠.噴霧干燥法制備川芎嗪殼聚糖微球的研究[J].中草藥,2008(05):679-682.

[118]夏愛(ài)曉,馮健,李范珠.微透析技術(shù)及其在經(jīng)皮給藥系統(tǒng)中的應(yīng)用[J].中國(guó)醫(yī)藥工業(yè)雜志,2008(05):378-382.

[119]趙寧,程巧鴛,俞文英,李范珠.微透析技術(shù)在藥動(dòng)-藥效學(xué)結(jié)合研究中的應(yīng)用[J].國(guó)際藥學(xué)研究雜志,2008(02):100-106.DOI:10.13220/j.cnki.jipr.2008.02.026.

[120]程巧鴛,馮健,李范珠.神經(jīng)毒素-I納米粒鼻腔給藥的腦內(nèi)遞送研究[J].藥學(xué)學(xué)報(bào),2008(04):431-434.DOI:10.16438/j.0513-4870.2008.04.020.

[121]李范珠,馮耀榮,馮健.鹽酸川芎嗪大鼠鼻腔給藥腦內(nèi)藥動(dòng)學(xué)研究[J].中國(guó)藥學(xué)雜志,2008(06):452-454.

[122]鄭紅月,俞文英,李范珠.中醫(yī)藥院校圖書(shū)館的特色信息服務(wù)與啟示[J].圖書(shū)館學(xué)刊,2008(01):64-65+85.

[123]潘越芳,李范珠.腦微透析技術(shù)及其在腦內(nèi)藥動(dòng)/藥效學(xué)研究中的應(yīng)用[J].中國(guó)藥物與臨床,2008(01):5-8.

[124]徐燕立,阮葉萍,林玉燕,萬(wàn)曼莉,李范珠,徐珊.健力顆粒對(duì)運(yùn)動(dòng)性疲勞免疫功能影響的實(shí)驗(yàn)研究[J].中華中醫(yī)藥雜志,2007(12):881-883.

[125]李范珠,張如松,趙寧,俞文英.產(chǎn)學(xué)研合作,培養(yǎng)創(chuàng)新型人才[J].科技管理研究,2007(12):195-196.

[126]徐燕立,阮葉萍,林玉燕,萬(wàn)曼莉,李范珠,徐珊.健力顆粒對(duì)運(yùn)動(dòng)性疲勞能量代謝與自由基影響的實(shí)驗(yàn)研究[J].中國(guó)中醫(yī)藥科技,2007(06):404-405.

[127]王冶閩,李范珠.蛋白多肽類(lèi)藥物微球鼻腔給藥的研究進(jìn)展[J].中國(guó)藥物與臨床,2007(10):737-739.

[128]蔡鑫君,馮健,程巧鴛,李范珠.疫苗微粒鼻腔給藥系統(tǒng)的研究進(jìn)展[J].藥學(xué)進(jìn)展,2007(09):391-397.

[129]程巧鴛,李范珠.神經(jīng)毒素納米粒的制備及大鼠鼻腔給藥的藥動(dòng)學(xué)研究[J].中國(guó)醫(yī)藥工業(yè)雜志,2007(09):636-637+661.

[130]馮耀榮,程巧鴛,李范珠.自乳化藥物傳遞系統(tǒng)的研究進(jìn)展[J].國(guó)際藥學(xué)研究雜志,2007(04):280-284.DOI:10.13220/j.cnki.jipr.2007.04.052.

[131]程巧鴛,李范珠.近五年經(jīng)方配伍規(guī)律的研究進(jìn)展[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2007(07):66-69.DOI:10.13422/j.cnki.syfjx.2007.07.028.

[132]李范珠,馮健,柴國(guó)寶,金桂.藥學(xué)大類(lèi)實(shí)驗(yàn)教學(xué)模式與方法改革探討[J].藥學(xué)教育,2007(02):39-41.DOI:10.16243/j.cnki.32-1352/g4.2007.02.015.

[133]程巧鴛,李范珠.神經(jīng)毒素納米粒大鼠鼻腔給藥的腦藥物動(dòng)力學(xué)研究[J].中國(guó)藥科大學(xué)學(xué)報(bào),2007(01):77-79.

[134]李范珠,胡晉.阿霉素納米囊的制備工藝及其毒性試驗(yàn)[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2006(06):474-477.DOI:10.13748/j.cnki.issn1007-7693.2006.06.018.

[135]張麗艷,李范珠.微透析技術(shù)在藥物靶組織分布和代謝研究中的應(yīng)用[J].中國(guó)新藥雜志,2006(24):2103-2106+2146.

[136]李范珠,金桂.中藥藥劑學(xué)劑型實(shí)驗(yàn)教學(xué)改革探討[J].中醫(yī)教育,2006(06):37-40.

[137]李范珠,潘旭旺.小鼠微透析技術(shù)及其在藥物傳遞系統(tǒng)中的應(yīng)用[J].藥學(xué)學(xué)報(bào),2006(10):921-926.DOI:10.16438/j.0513-4870.2006.10.003.

[138]李范珠,潘越芳.拓寬專(zhuān)業(yè)方向,培養(yǎng)新型中藥人才[J].醫(yī)學(xué)與社會(huì),2006(08):39-41.

[139]徐銘,李范珠.微透析取樣技術(shù)及其在體內(nèi)藥物分析中的應(yīng)用[J].藥物分析雜志,2006(07):1030-1034.

[140]李范珠,俞文英.中藥學(xué)專(zhuān)業(yè)課程與教材體系建設(shè)的改革探討[J].藥學(xué)教育,2006(03):10-12.DOI:10.16243/j.cnki.32-1352/g4.2006.03.004.

[141]呂長(zhǎng)江,趙榮淑,李范珠.眼鏡蛇神經(jīng)毒素鼻黏膜透過(guò)性的研究[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2006(02):169-171.DOI:10.13748/j.cnki.issn1007-7693.2006.02.035.

[142]潘旭旺,李范珠.腎微透析技術(shù)及其在腎組織間液腺苷測(cè)定中的應(yīng)用[J].中華醫(yī)學(xué)雜志,2006(17):1221-1223.

[143]李范珠,程巧鴛.神經(jīng)毒素PLGA納米粒的制備及鼻黏膜給藥的藥動(dòng)學(xué)研究[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2006(02):211-213+216.DOI:10.16466/j.issn1005-5509.2006.02.032.

[144]李范珠,馮健.腦微透析技術(shù)及其在腦內(nèi)藥動(dòng)學(xué)中的應(yīng)用[J].中國(guó)藥學(xué)雜志,2006(06):405-407.

[145]李范珠,俞麗霞,徐蓮英.眼鏡蛇神經(jīng)毒素粉末劑的鼻黏膜纖毛毒性考察[J].中國(guó)醫(yī)院藥學(xué)雜志,2006(01):1-3.

[146]朱文靜 ,李范珠.蛋白多肽類(lèi)藥物鼻黏膜給藥直接入腦途徑的研究進(jìn)展[J].中國(guó)藥物與臨床,2005(10):731-734.

[147]韓飛飛,吳綿斌,李范珠.對(duì)乙酰氨基酚中空栓的研制及其質(zhì)量考查[J].天津藥學(xué),2005(04):32-34.

[148]馮健,李范珠.促蛋白多肽類(lèi)藥物經(jīng)鼻黏膜吸收的研究進(jìn)展[J].中國(guó)藥學(xué)雜志,2005(15):1128-1130+1175.

[149]李范珠,程巧鴛,朱文靜.浙江眼鏡蛇蛇毒中神經(jīng)毒素的分離純化及其鎮(zhèn)痛作用研究[J].中國(guó)藥師,2004(09):659-661.

[150]劉志賢,李范珠,陳建明,方劍文.~(125)I-眼鏡蛇神經(jīng)毒素透鼻黏膜吸收及冰片的促進(jìn)作用研究[J].藥學(xué)實(shí)踐雜志,2004(04):200-202.

[151]程巧鴛,朱文靜,李范珠.鼻腔給藥的生物利用度研究進(jìn)展[J].國(guó)外醫(yī)學(xué)(藥學(xué)分冊(cè)),2004(03):168-172.DOI:10.13220/j.cnki.jipr.2004.03.012.

[152]俞麗霞,李范珠.鼻腔給藥研究進(jìn)展[J].浙江中醫(yī)學(xué)院學(xué)報(bào),2001(03):74-76.DOI:10.16466/j.issn1005-5509.2001.03.058.

[153]王澤時(shí),俞麗霞,李范珠.復(fù)方中藥研究的思路與體會(huì)[J].浙江中醫(yī)學(xué)院學(xué)報(bào),2000(01):83-84.DOI:10.16466/j.issn1005-5509.2000.01.035.

[154]李范珠,王選琛,劉志賢.金石散膠囊質(zhì)量標(biāo)準(zhǔn)的研究[J].中成藥,1998(06):45-47.

[155]王冰,李范珠,徐興家,王玉滿.狼把草的生藥鑒定研究[J].時(shí)珍國(guó)藥研究,1997(03):49.

[156]李范珠,康廷國(guó),呂佳,顏凱新.水飛薊素·β－環(huán)糊精包合物的研究[J].時(shí)珍國(guó)藥研究,1996(03):20-22.

[157]王冰,李范珠,徐興家,王玉滿.小花鬼針草的生藥鑒定[J].中國(guó)中藥雜志,1995(09):521-523.

發(fā)表會(huì)議論文：

[1]王彬輝;張超;章文紅;李范珠;高曉宇;陳玲;葉曉莉. 姜黃素聚乙二醇-聚己內(nèi)酯納米粒的藥動(dòng)學(xué)及其體外抗腫瘤研究[C].2018年浙江省醫(yī)學(xué)會(huì)臨床藥學(xué)分會(huì)學(xué)術(shù)年會(huì)論文匯編.2018:71-72.

[2]王彬輝;鄒杰;章文紅;李范珠;高曉宇;陳玲;葉曉莉. 姜黃素聚乙二醇-聚己內(nèi)酯納米粒的制備及制劑學(xué)性質(zhì)分析[C].2018年浙江省醫(yī)學(xué)會(huì)臨床藥學(xué)分會(huì)學(xué)術(shù)年會(huì)論文匯編.2018:72-73.

[3]方羅,鐘里科,張軼雯,丁海櫻,辛文秀,童瑩慧,李范珠,黃萍. 積雪草酸腫瘤基質(zhì)重塑作用提高聚乙二醇修飾的多柔比星脂質(zhì)體的瘤內(nèi)濃度及其抗腫瘤作用研究(英文)[C]. 2016年臨床藥學(xué)高峰論壇暨浙江省醫(yī)學(xué)會(huì)臨床藥學(xué)分會(huì)學(xué)術(shù)會(huì)議論文匯編. 2016:185-186.

[4]李范珠. Development evolution of nanoparticles and its application in practice[C]. 2016年中國(guó)藥物制劑大會(huì)、中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)2016年學(xué)術(shù)年會(huì)、中國(guó)化學(xué)制藥工業(yè)協(xié)會(huì)固體制劑專(zhuān)業(yè)委員會(huì)2016年工作年會(huì)、國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)2016年學(xué)術(shù)年會(huì)會(huì)議論文集. 2016:67+66.

[5]費(fèi)偉東,韓順平,施曉偉,陶成浩,李范珠. RGD containing lipid coated arsenic trioxide-loaded hollow mesoporous silica nanoparticles for treatment of cancer cell[C]. 2015年中國(guó)藥物制劑大會(huì)暨中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)2015年學(xué)術(shù)年會(huì)暨國(guó)際釋控協(xié)會(huì)中國(guó)分會(huì)2015年學(xué)術(shù)年會(huì)會(huì)議論文集. 2015:300.

[6]李范珠. Design of Smart Targeted Nanocarriers as Drug Delivery System[C]. 2015年中國(guó)藥物制劑大會(huì)暨中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)2015年學(xué)術(shù)年會(huì)暨國(guó)際釋控協(xié)會(huì)中國(guó)分會(huì)2015年學(xué)術(shù)年會(huì)會(huì)議論文集. 2015:73.

[7]樓成華,李范珠. Identification of Hirsutine as a novel anti-cancer phytochemical and exploration of its anti-tumor mechanism against breast cancer[C]. 浙江省毒理學(xué)會(huì)第二屆學(xué)術(shù)年會(huì)論文集. 2015:81-82.

[8]胡亦沁,李范珠. 半制備液相色譜分離制備熒光單標(biāo)記的眼鏡蛇神經(jīng)毒素[C]. 中華中醫(yī)藥學(xué)會(huì)第七次中藥分析學(xué)術(shù)交流會(huì)會(huì)議論文集. 2014:413-417.

[9]廖廣輝,倪珊珊,洪寅,申力,錢(qián)旭武,張廣順,李范珠,張光霽. As2O3聯(lián)合隱丹參酮抑制肝癌HepG2細(xì)胞裸鼠移植瘤的量效研究(摘要)[C]. 中華中醫(yī)藥學(xué)會(huì)2014第七次臨床中藥學(xué)術(shù)研討會(huì)論文集. 2014:20-21.

[10]倪珊珊,廖廣輝,張廣順,申力,錢(qián)旭武,李范珠,張光霽. As2O3與隱丹參酮不同配比對(duì)人肝癌HepG2裸鼠的影響(摘要)[C]. 中華中醫(yī)藥學(xué)會(huì).中華中醫(yī)藥學(xué)會(huì)2014第七次臨床中藥學(xué)術(shù)研討會(huì)論文集.中華中醫(yī)藥學(xué)會(huì):中華中醫(yī)藥學(xué)會(huì),2014:91-92.

[11]胡亦沁,Xu Jun-jun,Guo Man-man,Wang Guo-wei,李范珠. Study on FITC-Neurotoxin loaded Angiopep-2 Modified Nanoparticles[C]. 中國(guó)藥學(xué)會(huì)（Chinese Pharmaceutical Association）.2014中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、第六屆亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議論文集.中國(guó)藥學(xué)會(huì)（Chinese Pharmaceutical Association）:中國(guó)藥學(xué)會(huì),2014:380.

[12]JunjunXu; GuoweiWang; ManmanGuo; WeidongFei; FanzhuLi. In vivo delivery of exenatide with mesoporous silicon nanoparticles as vehicles[C]. 2014中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、第六屆亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議論文集. 2014:324.  China,Hunan,Changsha, 2014-09-21.

[13]GuoweiWang; JunjunXu; ManmanGuo; RongrongZhang; WeidongFei; FanzhuLi。A Novel Core-Shell Structural Phospholipid-Functionalized Mesoporous Silica Nanoparticles Modified with Angiopep-2 as Targeting Drug Delivery System for Brain Glioma。China,Hebei,Shijiazhuang, 2014-10-24.

[14]ManmanGuo; GuoweiWang; JianiGuan; JunjunXu; FanzhuLi。Arsenic trioxide-loaded pH-responsive mesoporous silica nanoparticles:preparation, in vitro release and pharmacokinetic studies in rats。China,Hunan,Changsha, 2014-09-21.

[15]李范珠�？共《局兴幥熬胺治�。中國(guó),山東省,煙臺(tái)市.

[16]郭曼曼; 王國(guó)偉; 王叢瑤; 管佳妮; 魏穎慧; 李范珠。腫瘤靶向唑來(lái)膦酸陽(yáng)離子脂質(zhì)體的研究。中國(guó),浙江省,杭州市.

[17]王國(guó)偉; 郭曼曼; 高曉宇; 管佳妮; 魏穎慧; 李范珠。姜黃素聚乙二醇-聚已內(nèi)酯納米粒的制備及其體外抗腫瘤活性。中國(guó),浙江省,杭州市.
 
[18]LiFanzhu; WeiYinghui; GuanJiani; LiuMinchen。Preparation,in vitro release,pharmacokinetics and tissue distribution of norcantharidin loaded to poly (MePEGcyanoacrylate-co-hexadecylcyanoacrylate) nanoparticles in beagle dogs and SD rats determined by LC-MS/MS。China,Hubei,Wuhan, 2013-10-26.

[19]WangGuowei; XuJunjun; GuoManman; LiYingfang; WeiYinghui; LiFanzhu。Preparation of borneol and brucea javanica oil nanoemulsion and tumor suppression effect on glioma in rats。China,Hubei,Wuhan, 2013-10-26.

[20]MinChenLiu; WuChaoLi; YunyiYu; XiaoguangShang; FanZhuLi。Preparation,in vitro release,and pharmacokinetics of norcantharidin loaded to MePEG-PHDCA nanoparticles using LC-MS/MS for its determination。China,Zhejiang,Hangzhou, 2013-06-01.

[21]Guowei Wang; Junjun Xu; Manman Guo; Rongrong Zhang; Weidong Fei; Fanzhu Li。Drug Delivery System for Brain Glioma。A Novel Core-Shell Structural Phospholipid-Functionalized Mesoporous Silica Nanoparticles Modified with Angiopep-2 as Targeting 。

[22]MinChen Liu; WuChao Li; Yunyi Yu; Xiaoguang Shang; FanZhu Li. Preparation,in vitro release,and pharmacokinetics of norcantharidin loaded to MePEG-PHDCA nanoparticles using LC-MS/MS for its determination.

[23]MinChenLiu; XiaoqiongM; WuChaoLi; FanZhuLi. Development of a LC-MS/MS method for the determination of norcantharidin in beagle plasma and its application to the pharmacokinetic study. China,Zhejiang,Hangzhou, 2013-06-01.

[24] LiFanzhu. Galactose-specific PEGylated PHDCA nanoparticles for active liver targeting delivery of Norcantharidin. China,Sichuan,Chengdu.

[25]郭曼曼,管佳妮,王國(guó)偉,高曉宇,方羅,李范珠. 姜黃素PEG-PCL納米粒的制備及藥動(dòng)學(xué)和體外抑瘤作用研究[C]. 抗腫瘤藥物研究新進(jìn)展與腫瘤個(gè)性化藥物治療論壇論文集. 2013:169-180.

[26]王國(guó)偉,徐駿軍,郭曼曼,李穎芳,方羅,李范珠. 冰片鴉膽子油納米乳的制備及對(duì)大鼠腦膠質(zhì)瘤抑瘤作用研究[C]. 抗腫瘤藥物研究新進(jìn)展與腫瘤個(gè)性化藥物治療論壇論文集. 2013:247-255.

[27]王國(guó)偉,徐駿軍,戴東波,魏穎慧,諸佳珍,李范珠. 四逆湯噴干粉中烏頭生物堿大鼠體內(nèi)吸收動(dòng)力學(xué)研究[C]. 2013全國(guó)中藥與天然藥物高峰論壇暨第十三屆全國(guó)中藥和天然藥物學(xué)術(shù)研討會(huì)論文集. 2013:93.

[28]李武超,劉敏臣,李范珠. LC-MS/MS法測(cè)定去甲斑蝥素在大鼠體內(nèi)的組織分布[C]. 2013全國(guó)中藥與天然藥物高峰論壇暨第十三屆全國(guó)中藥和天然藥物學(xué)術(shù)研討會(huì)論文集. 2013:94.

[29]諸佳珍,張蓉蓉,李晶晶,孫悅,李范珠. 當(dāng)歸補(bǔ)血顆粒對(duì)大鼠腎缺血再灌注損傷保護(hù)作用機(jī)制研究[C]. 2013全國(guó)中藥與天然藥物高峰論壇暨第十三屆全國(guó)中藥和天然藥物學(xué)術(shù)研討會(huì)論文集. 2013:95.

[30]高曉宇,李范珠. Preparation and Pharmacokinetic Study of Puerarin loaded Nanostructured Lipid Carriers[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:348.

[31]曹陽(yáng),李范珠. The enhancement effect of borneol on pharmacodynamics in rat brain of anticancer drug Irinotecan[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:354.

[32]劉敏臣,李范珠. Galactose-specific PEGylated PHDCA nanoparticles for active Norcantharidin delivery in hepatocellular carcinoma[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:355.

[33]李范珠. Galactose-specific PEGylated PHDCA nanoparticles for active liver targeting delivery of Norcantharidin[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:190-198.

[34]陳修克,李范珠. Preparation and in Vitro Release of Nimodipine/Tertramethylpyrazine-loaded PLGA Nanoparticles[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:349.

[35]王叢瑤,李范珠. Preparation and in vitro Release of adriamycin hydrochloride chitosan nanoparticles[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:350.

[36]金滔,李范珠. Preparation and Brain Delivery Evaluation of Temozolomide-Loaded Albumin Nanoparticles[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:351.

[37]金倩倩,李范珠. Study on Vincristine Sulfate-Loaded Solid Lipid Nanoparticles[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:352.

[38]李穎芳,李范珠. Preparation and in vitro release of Rifampicin-ioaded poly(lactic-co-glycolic acid) nanoparticles[C]. 2012年中國(guó)藥物制劑大會(huì)——中國(guó)藥學(xué)會(huì)藥劑專(zhuān)業(yè)委員會(huì)年會(huì)、亞洲阿登制藥技術(shù)研討會(huì)暨國(guó)際控釋協(xié)會(huì)中國(guó)分會(huì)年會(huì)會(huì)議資料. 2012:353.

[39]鄭杭生,高曉宇,王叢瑤,魏穎慧,徐秀玲,葉嬌云,李范珠. 氨茶堿貼片的制備及家兔臍部給藥的藥動(dòng)學(xué)研究[C]. 第十一屆全國(guó)青年藥學(xué)工作者最新科研成果交流會(huì)論文集. 2012:1117-1127.

[40]諸佳珍,李范珠. 阿霉素自組裝納米粒的制備及其抗腫瘤活性的研究[C]. 第十一屆全國(guó)青年藥學(xué)工作者最新科研成果交流會(huì)論文集. 2012:1184-1192.

[41]魏穎慧,趙燕敏,陳修克,郭曼曼,李范珠. 殼聚糖修飾的雷公藤多苷納米粒的制備及體外釋藥研究[C]. 第十一屆全國(guó)青年藥學(xué)工作者最新科研成果交流會(huì)論文集. 2012:816-825.

[42]徐秀玲,王叢瑤,鄭杭生,陳蘋(píng)蘋(píng),金滔,李范珠. 鹽酸阿霉素殼聚糖納米粒大鼠鼻腔給藥的腦內(nèi)藥動(dòng)學(xué)研究[C]. 第十一屆全國(guó)青年藥學(xué)工作者最新科研成果交流會(huì)論文集. 2012:881-891.

[43]廖廣輝,李范珠,宋捷民,李如輝. 藥對(duì)組配決定論及研究思路探討[C]. 全國(guó)第3屆臨床中藥學(xué)學(xué)術(shù)研討會(huì)論文集. 2010:352-354.

[44]倪玲,李范珠. 離心造粒法制備生血微丸的研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:4946-4953.

[45]彭璇,陳萍萍,包強(qiáng),魏穎慧,李范珠. 水飛薊賓過(guò)飽和自乳化給藥系統(tǒng)的制備及性質(zhì)研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:4963-4973.

[46]王彬輝,馮健,趙燕敏,魏穎慧,徐銘,李范珠. 附子中烏頭類(lèi)生物堿在大鼠體內(nèi)的藥動(dòng)學(xué)研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:5073-5081.

[47]陳蘋(píng)蘋(píng),葉曉莉,諸佳珍,李范珠. 液相色譜-電噴霧串聯(lián)質(zhì)譜法分析四逆湯中烏頭堿在大鼠尿液中的代謝產(chǎn)物[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:7263-7272.

[48]包強(qiáng),尚小廣,宋倩倩,李范珠. pH依賴(lài)-時(shí)滯型大黃素結(jié)腸定位微丸的制備及體外釋放度研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集.中國(guó)藥學(xué)會(huì)(Chinese Pharmaceutical Association)、天津市人民政府:中國(guó)藥學(xué)會(huì),2010:7533-7542.

[49]劉福和,金桂,王斌艷,魏穎慧,李范珠. 吐溫-80包裹的神經(jīng)毒素納米粒鼻腔給藥腦內(nèi)遞送的研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:4876-4882.

[50]徐陸忠,趙燕敏,潘越芳,魏穎慧,李范珠. 神經(jīng)毒素納米粒的制備及在大鼠體內(nèi)的組織分布[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:5246-5254.

[51]趙燕敏,何曉瑋,姚金娜,李范珠. 聚山梨酯80修飾的神經(jīng)毒素納米�？缪�腦屏障攝取和外排研究[C]. 2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集. 2010:6800-6810.

[52]馮健,李范珠. 低共熔吸收促進(jìn)劑對(duì)神經(jīng)毒素鼻腔給藥腦內(nèi)遞藥的影響[C]. 2010施慧達(dá)杯第十屆全國(guó)青年藥學(xué)工作者最新科研成果交流會(huì)論文集. 2010:438-444.

[53]倪玲,李范珠. 離心造粒法制備生血微丸的研究[C]. 2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集. 2009:2526-2533.

[54]王彬輝,馮健,趙燕敏,魏穎慧,徐銘,李范珠. 附子中烏頭類(lèi)生物堿在大鼠體內(nèi)的藥動(dòng)學(xué)研究[C]. 2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集. 2009:2603-2611.

[55]劉福和,金桂,王斌艷,魏穎慧,李范珠. 吐溫-80包裹的神經(jīng)毒素納米粒鼻腔給藥腦內(nèi)遞送的研究[C]. 2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集. 2009:2494-2500.

[56]彭璇,陳萍萍,包強(qiáng),魏穎慧,李范珠. 水飛薊賓過(guò)飽和自乳化給藥系統(tǒng)的制備及性質(zhì)研究[C]. 2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集. 2009:2534-2545.

[57]徐陸忠,趙燕敏,潘越芳,魏穎慧,李范珠. 神經(jīng)毒素納米粒的制備及在大鼠體內(nèi)的組織分布[C]. 2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集. 2009:2688-2697.

[58]倪玲,李范珠. 離心造粒法制備生血微丸的研究[C]. 2009全國(guó)中藥創(chuàng)新與研究論壇學(xué)術(shù)論文集. 2009:212-217.

[59]彭璇,陳萍萍,包強(qiáng),魏穎慧,李范珠. 水飛薊賓過(guò)飽和自乳化給藥系統(tǒng)的制備及性質(zhì)研究[C]. 2009全國(guó)中藥創(chuàng)新與研究論壇學(xué)術(shù)論文集. 2009:71-78.

[60]王彬輝,馮健,趙燕敏,魏穎慧,徐銘,李范珠. 附子中烏頭類(lèi)生物堿在大鼠體內(nèi)的藥動(dòng)學(xué)研究[C]. 2009全國(guó)中藥創(chuàng)新與研究論壇學(xué)術(shù)論文集. 2009:463-468.

[61]劉福和,金桂,王斌艷,魏穎慧,李范珠. 吐溫-80包裹的神經(jīng)毒素納米粒鼻腔給藥腦內(nèi)遞送的研究[C]. 2009全國(guó)中藥創(chuàng)新與研究論壇學(xué)術(shù)論文集. 2009:478-482.

[62]徐陸忠,趙燕敏,潘越芳,魏穎慧,李范珠. 神經(jīng)毒素納米粒的制備及在大鼠體內(nèi)的組織分布[C]. 2009全國(guó)中藥創(chuàng)新與研究論壇學(xué)術(shù)論文集. 2009:483-488.

[63]李范珠,張如松,阮葉萍,胡一平,丁宇霞. 構(gòu)建藥學(xué)專(zhuān)業(yè)實(shí)驗(yàn)教學(xué)新模式的探索[C]. 2008年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2008:148-150.

[64]李范珠,張如松,阮葉萍,胡一平,丁宇霞. 高校科研實(shí)驗(yàn)室在大學(xué)生創(chuàng)新能力培養(yǎng)方面的作用[C]. 2008年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2008:124-126.

[65]柴國(guó)寶,夏愛(ài)曉,蔡鑫君,魏穎慧,馮健,李范珠. 冰片-薄荷腦低共熔物對(duì)納米粒鼻腔給藥載藥入腦的影響[C]. 2008年中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)暨第八屆中國(guó)藥師周論文集. 2008:2145-2151.

[66]蔡鑫君,夏愛(ài)曉,柴國(guó)寶,魏穎慧,馮健,李范珠. 噴霧干燥法制備神經(jīng)毒素殼聚糖鼻腔給藥微球的研究[C]. 2008年中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)暨第八屆中國(guó)藥師周論文集. 2008:2139-2144.

[67]李范珠,柴國(guó)寶,潘越芳. 冰片-薄荷腦低共熔物對(duì)納米粒鼻腔給藥載藥入腦的影響[C]. 中華中醫(yī)藥學(xué)會(huì)第九屆制劑學(xué)術(shù)研討會(huì)論文匯編. 2008:182-185.

[68]李范珠,倪玲,俞文英,魏穎慧. 生血微丸膠囊質(zhì)量標(biāo)準(zhǔn)的研究[C]. 中華中醫(yī)藥學(xué)會(huì)第九屆制劑學(xué)術(shù)研討會(huì)論文匯編 2008:292-296.

[69]李范珠,柴國(guó)寶,馮健,魏穎慧. 載脂蛋白修飾PBCA納米粒介導(dǎo)藥物跨血腦屏障的研究進(jìn)展[C]. 中華中醫(yī)藥學(xué)會(huì)第九屆制劑學(xué)術(shù)研討會(huì)論文匯編. 2008:386-391.

[70]何曉瑋; 葉曉莉; 宋倩倩; 尚小廣; 諸佳珍; 姚金娜; 李范珠，不同促滲劑對(duì)氨茶堿貼片體外經(jīng)皮滲透的影響，中國(guó),云南省,昆明市.

[71] FanzhuLi; JianFeng; YaorongFeng; QiaoyuanCheng。Brain pharmacokinetics of Tetramethylpyrazine in free-moving rats using microdialysis: A comparison of nasal and intravenous delivery。China,Shanghai, 2007-01-01.

[72]QiaoyuanCHENG; WenjingZHU; JianFENG; JianmingCHEN; FanzhuLI。Brain Transport of Neurotoxin-I With PLA Nanoparticles Through Intranasal Administration in Rats: A Microdialysis Study。China,Shanghai, 2007-01-01.

[73]李范珠; 張如松，藥學(xué)實(shí)驗(yàn)教學(xué)與科學(xué)研究融合的探索與實(shí)踐，中國(guó),北京市.

[74]李范珠,張如松,阮葉萍,薛莉莉,胡一平,丁宇霞. 藥學(xué)類(lèi)教學(xué)實(shí)驗(yàn)中心建設(shè)與管理初探[C]. 2007年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2007:113-116.

[75]李范珠,馮健,柴國(guó)寶,金桂. 藥學(xué)大類(lèi)實(shí)驗(yàn)教學(xué)模式與方法改革探討[C]. 2007年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2007:182-184.

[76]程巧鴛,李范珠. 乳酸/羥基乙酸共聚物為載體的神經(jīng)毒素緩釋納米粒的制備及特性研究[C]. 2006第六屆中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)論文集. 2006:1596-1602.

[77]潘旭旺,李范珠. 冰茶鼻粉劑與栓劑的藥物動(dòng)力學(xué)研究[C]. 2006第六屆中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)論文集. 2006:1699-1706.

[78]李范珠,張麗艷,徐銘. 神經(jīng)毒素鼻粉劑的制備及其體外釋藥與在體吸收特性考察[C]. 2006第六屆中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)論文集. 2006:1752-1761.

[79]李范珠,馮耀榮,程巧鴛,馮健. 鹽酸川芎嗪大鼠鼻腔給藥的腦內(nèi)藥動(dòng)學(xué)研究[C]. 2006第六屆中國(guó)藥學(xué)會(huì)學(xué)術(shù)年會(huì)論文集. 2006:1825-1831.

[80]李范珠,張如松. 中藥專(zhuān)業(yè)課程與教材體系的改革與探索[C]. 005年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2005:117-120.

[81]李范珠,張如松. 深化教學(xué)改革,探索復(fù)合型中藥人才的培養(yǎng)[C]. 2005年浙江省醫(yī)學(xué)教育學(xué)術(shù)年會(huì)論文匯編. 2005:124-126.